2nd Annual Breast Cancer Symposium: Learning Objectives

This conference targets licensed health care providers and educators from a variety of settings with interest in improving knowledgte, skills, and practice in the area of breast cancer

 Upon completion of the course, participants will be able to: 

• Determine patient’s candidacy for current clinical breast trials.

• Realize clinical breast trials and know where to direct patients for enrollment.

• Distinguish between benign vs. malignant masses in the male breast.

• Appreciate the advantages of radioactive seed placement over traditional wire localization to the patient, surgeon, radiologist and hospital.

• Recognize the role of the Radiologist and Surgeon when a radioactive seed is placed for localization of a non-palpable breast mass.

• Navigate the breast cancer patient.

• Stage a breast cancer patient.

• Appreciate survivorship, what it means and how we follow breast cancer patients.

• Understand the connection between BRCA1 mutations and Triple Negative Breast Cancers.

• Comprehend the gynecologic guidelines and recommendations for the BRCA patient.

• Identify the surgical approach and folloow-up for the BRCA patient.

• Identify patients who would benefit from Oncoplastic Technique in Breast Reconstruction.

• Discuss TARGIT Trial Data.

• Identify patients eligible for US Intraoperative Registry Trial (TARGIT-US).

• Understand current evidence regarding genetic testing in individuals with Triple Negative Breast Cancers.

• Recognize points of quality of life concerns along the breast cancer care continuum. 

• Distinquish between candidacy for palliative care or hospice care referral.

• Diminsh liability risk through appropriate documentations.

• Establish appropriate practice processes to enhance patient outcomes and reduce errors.